Changing the game: Next-generation DNAzymes for antiviral therapies
Projektnummer
0070230
Zusammenfassung
The inherent capabilities of specific DNA sequences, so-called DNAzymes, to selectively eliminate unwanted RNA molecules pose an outstanding antiviral potential. However, reduced cellular activity frequently limits DNAzyme therapeutic applications. This proposal aims to overcome the persisting limitations by developing novel DNAzyme variants with strongly increased antiviral efficacy. To achieve this goal, the interdisciplinary project team will exploit their recently obtained new mechanistic understanding of the system and address the DNAzyme's persisting antiviral limitations via in ...
Projektinformationen
Status:
Durchführung
Startdatum:
01.12.2022
Enddatum:
31.03.2026
Fördersumme:
698.400 €
Profilbereich:
Exploration
Förderinitiative:
Innovative Ansätze in der antiviralen Wirkstoffentwicklung